 | Protara Therapeutics, Inc. | |||
| NGM : TARA || Location: United States | ||||
$2.64-0.11 (-4.0%) |
0.21 M | 2.61 - 2.8 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.065 M |
| March 15, 2024 | 0.061 M |
| Feb. 29, 2024 | 0.079 M |
| Feb. 15, 2024 | 0.059 M |
| Jan. 31, 2024 | 0.088 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.94 | -0.90 | 3.84% |
| 09/30/2023 | -1.00 | -0.87 | 12.97% |
| 03/31/2023 | -0.89 | -0.80 | 10.56% |
| 12/31/2022 | -0.76 | -1.55 | -102.61% |
| 09/30/2022 | -0.76 | -0.68 | 10.50% |
TARA Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 11.434M | Shares Float | 6.500M |
| Short Float | 0.065M | Market Cap | 30.19M |
| Institution ownership | 44.16% | Insider ownership | 16.594% |
| Earnings Date | 05/02/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -3.57 | Forward EPS | -4.23 |